Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability (Q50276198)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 May 2015

edit

Language	Label	Description	Also known as
English	Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability	scientific article published on 16 May 2015

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

retrieved

28 February 2018

reference URL

http://europepmc.org/abstract/MED/25983109

title

Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

retrieved

28 February 2018

reference URL

http://europepmc.org/abstract/MED/25983109

main subject

aflibercept

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

author

Yasuo Yanagi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25983109%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

author name string

Yoko Nomura

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25983109%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

publication date

16 May 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

retrieved

28 February 2018

reference URL

http://europepmc.org/abstract/MED/25983109

published in

Japanese Journal of Ophthalmology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25983109%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

volume

59

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25983109%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25983109%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

page(s)

261-265

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25983109%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

cites work

Choroidal capillary and venous congestion in central serous chorioretinopathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Indocyanine green angiography is of value for the diagnosis of chronic central serous chorioretinopathy in elderly patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Choroidal neovascularization in eyes with choroidal vascular hyperpermeability

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Widespread choroidal thickening and abnormal midperipheral fundus autofluorescence characterize exudative age-related macular degeneration with choroidal vascular hyperpermeability.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

ANTI-VEGF TREATMENT IN NEOVASCULAR AGE–RELATED MACULAR DEGENERATION

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10384-015-0387-Z

retrieved

21 January 2018

Effects of vitreomacular adhesion on ranibizumab treatment in Japanese patients with age-related macular degeneration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/25983109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central serous chorioretinopathy in younger and older adults

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/25983109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/25983109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central serous chorioretinopathy and indocyanine green angiography.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/25983109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/25983109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10384-015-0387-Z

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25983109%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

PubMed publication ID

25983109

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25983109

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25983109%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 June 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50276198&oldid=2247639824"